February 15, 2026
Headlines

Merck Scores Positive Feedback From EU Agency Regarding Blockbuster Cancer Drug

Sumain Faisal01 mins

Merck received positive Keytruda notes from CHMP regarding its breakthrough cancer treatment with final decisions expected in late 2025.

read more

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News